Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2024 | 06-2023 | 06-2022 | 06-2021 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,171 | 5,905 | 4,168 | 91 | 7 |
| Other Operating Activity | -11,519 | -12,451 | -8,274 | -4,795 | -3,842 |
| Operating Cash Flow | $-6,348 | $-6,546 | $-4,106 | $-4,704 | $-3,836 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -22 | -12 | -46 | -559 | -1 |
| Net Acquisitions | N/A | -327 | -2,467 | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | -24 | N/A | N/A |
| Other Investing Activity | 97 | 129 | 3 | 0 | 44 |
| Investing Cash Flow | $75 | $-210 | $-2,511 | $-559 | $44 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 394 | N/A | N/A | N/A | 35 |
| Common Stock Issued | 1,690 | 4,829 | N/A | 11,879 | 14,635 |
| Other Financing Activity | -233 | -843 | -203 | -1,650 | -2,341 |
| Financing Cash Flow | $1,851 | $3,985 | $-203 | $10,229 | $12,329 |
| Exchange Rate Effect | -58 | 158 | 166 | 32 | -424 |
| Beginning Cash Position | 5,149 | 7,898 | 15,165 | 10,621 | 1,432 |
| End Cash Position | 669 | 5,285 | 8,511 | 15,618 | 9,545 |
| Net Cash Flow | $-4,480 | $-2,612 | $-6,654 | $4,997 | $8,113 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,348 | -6,546 | -4,106 | -4,704 | -3,836 |
| Capital Expenditure | -22 | -12 | -46 | -559 | -26 |
| Free Cash Flow | -6,369 | -6,557 | -4,152 | -5,264 | -3,861 |